Abstract: Mesenchymal stem cells (MSCs) are a promising tool in regenerative medicine due to their ability to secrete paracrine factors that modulate tissue repair. Extracellular vesicles (EVs) released by MSCs contain bioactive molecules (e.g., mRNAs, miRNAs, proteins) and play a key role in intercellular communication. This study compared the transcriptomic profiles (mRNA and miRNA) of equine MSCs derived from adipose tissue (AT-MSCs), bone marrow (BM-MSCs), and ovarian fibroblasts (as a differentiated control). Additionally, miRNAs present in EVs secreted by these cells were characterized using next-generation sequencing. All cell types met ISCT criteria for MSCs, including CD90 expression, lack of MHC II, trilineage differentiation, and adherence. EVs were isolated using ultracentrifugation and validated with nanoparticle tracking analysis and flow cytometry (CD63, CD81). Differential expression analysis revealed distinct mRNA and miRNA profiles across cell types and their secreted EVs, correlating with tissue origin. BM-MSCs showed unique regulation of genes linked to early development and osteogenesis. EVs contained diverse RNA species, including miRNA, mRNA, lncRNA, rRNA, and others. In total, 227 and 256 mature miRNAs were detected in BM-MSCs and AT-MSCs, respectively, including two novel miRNAs per MSC type. Fibroblasts expressed 209 mature miRNAs, including one novel miRNA also found in MSCs. Compared to fibroblasts, 60 and 92 differentially expressed miRNAs were identified in AT-MSCs and BM-MSCs, respectively. The results indicate that MSC tissue origin influences both transcriptomic profiles and EV miRNA content, which may help to interpret their therapeutic potential. Identifying key mRNAs and miRNAs could aid in future optimizing of MSC-based therapies in horses.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
Overview
This research compares the gene expression (mRNA and miRNA) profiles of different types of equine mesenchymal stem cells (MSCs) and fibroblasts, as well as the microRNAs found in their secreted extracellular vesicles (EVs), to better understand their molecular characteristics and potential for regenerative medicine.
Introduction to Mesenchymal Stem Cells and Extracellular Vesicles
MSCs have regenerative abilities largely due to their secretion of paracrine factors—bioactive molecules that facilitate tissue repair and wound healing.
Extracellular vesicles (EVs) are small membrane-bound particles released by cells that carry various molecules such as mRNAs, miRNAs, proteins, and other RNAs, which function in intercellular communication.
The study focuses on equine MSCs derived from two tissue types: adipose tissue (AT-MSCs) and bone marrow (BM-MSCs), and compares them to ovarian fibroblasts which act as a differentiated control cell type.
Methods and Cell Characterization
All cell types used in the study were validated to meet the International Society for Cellular Therapy (ISCT) criteria for MSCs:
Positive for CD90 surface marker
Negative for Major Histocompatibility Complex class II (MHC II) expression
Ability to differentiate into three lineages (trilineage differentiation)
Adherence to plastic culture surfaces
Extracellular vesicles were isolated using ultracentrifugation methods to ensure purity.
EVs were verified through:
Nano-particle tracking analysis (to determine size and concentration)
Flow cytometry for EV surface markers CD63 and CD81
Transcriptomic and miRNA Profiling
Next-generation sequencing was used to analyze mRNA and miRNA expression profiles from the MSCs, fibroblasts, and their respective EVs.
Distinct expression profiles were observed between the MSC types and fibroblasts, correlating with their tissue origins:
BM-MSCs had unique gene expression, especially in genes related to early development and bone formation (osteogenesis).
EVs contained a diverse array of RNA types beyond miRNAs, including long non-coding RNAs (lncRNAs), ribosomal RNAs (rRNAs), and messenger RNAs (mRNAs).
In terms of miRNAs detected:
AT-MSCs had 256 mature miRNAs, including 2 previously unidentified novel miRNAs.
BM-MSCs had 227 mature miRNAs, also including 2 novel miRNAs.
Fibroblasts expressed 209 mature miRNAs, including 1 novel miRNA that was also shared with MSCs.
Comparison between cell types revealed significant differences:
60 miRNAs were differentially expressed in AT-MSCs compared to fibroblasts.
92 miRNAs were differentially expressed in BM-MSCs compared to fibroblasts.
Biological and Therapeutic Implications
The tissue source of MSCs significantly influences both the comprehensive transcriptomic signatures and the miRNA cargo of their extracellular vesicles.
These molecular differences may underlie the distinct therapeutic potentials observed in MSCs derived from different tissues.
Identification of key mRNAs and miRNAs that are unique or enriched in MSCs or their EVs could inform the development and optimization of MSC-based regenerative therapies in horses.
This detailed molecular profiling can help in selecting the most appropriate MSC source or in engineering EVs with desired therapeutic properties.
Conclusion
This study provides comprehensive transcriptomic and microRNA profiles of equine MSCs from adipose and bone marrow sources compared to fibroblasts, together with characterization of their EV miRNA content.
It highlights the importance of MSC tissue origin on gene and miRNA expression, offering molecular insights critical for enhancing MSC-based treatments in veterinary regenerative medicine.
Cite This Article
APA
Sawicki S, Bugno-Poniewierska M, Żurowski J, Szmatoła T, Semik-Gurgul E, Bochenek M, Karnas E, Gurgul A.
(2025).
Comparative Transcriptome and MicroRNA Profiles of Equine Mesenchymal Stem Cells, Fibroblasts, and Their Extracellular Vesicles.
Genes (Basel), 16(8), 936.
https://doi.org/10.3390/genes16080936
Reynolds DE, Vallapureddy P, Morales R-TT, Oh D, Pan M, Chintapula U, Linardi RL, Gaesser AM, Ortved K, Ko J. Equine mesenchymal stem cell derived extracellular vesicle immunopathology biomarker discovery. J. Extracell. Biol. 2023;2:89.
Perrini C, Strillacci MG, Bagnato A, Esposti P, Marini M, Corradetti B, Bizzaro D, Idda A, Ledda S, Capra E. Microvesicles secreted from equine amniotic derived cells and their potential role in reducing inflammation in endometrial cells in an in-vitro model. Stem Cell Res. Ther. 2016;7:169.
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, Deans RJ, Keating A, Prockop DJ, Horowitz EM. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315–317.
Konala VBR, Mamidi MK, Bhonde R, Das AK, Pochampally R, Pal R. The current landscape of the mesenchymal stromal cell secretome: A new paradigm for cell-free regeneration. Cytotherapy 2016;18:13–24.
Pavani KC, Hendrix A, van Den Broeck W, Couck L, Szymanska K, Lin X, Koster JD, Soom AV, Leemans B. Isolation and characterization of functionally active extracellular vesicles from culture medium conditioned by bovine embryos in vitro. Int. J. Mol. Sci. 2018;20:38.
Yáñez-Mó M, Siljander PR-M, Andreu Z, Bedina Zavec A, Borràs FE, Buzas EI, Buzas K, Casal E, Cappello F, Carvalho J. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles. 2015;4:27066.
Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F, Atkin-Smith GK. Minimal information for studies of extracellular vesicles2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles. 2018;7:1535750.
Gandham S, Su X, Wood J, Nocera AL, Alli SC, Milane L, Zimmerman A, Amiji M, Ivanov AR. Technologies and standardization in research on extracellular vesicles. Trends Biotechnol. 2020;38:1066–1098.
Tetta C, Consiglio AL, Bruno S, Tetta E, Gatti E, Dobreva M, Cremonesi F, Camussi G. The role of microvesicles derived from mesenchymal stem cells in tissue regeneration; a dream for tendon repair?. Muscles Ligaments Tendons J 2012;2:212–221.
Collino F, Pomatto M, Bruno S, Lindoso RS, Tapparo M, Sicheng W, Quesenberry P, Camussi G. Exosome and microvesicle-enriched fractions isolated from mes- enchymal stem cells by gradient separation showed different molecular signatures and functions on renal tubular epithelial cells. Stem Cell Rev Rep 2017;13:226–243.
Pavani KC, Meese T, Pascottini OB, Guan X, Lin X, Peelman L, Hamacher J, Van Nieuwerburgh F, Deforce D, Boel A. Hatching is modulated by microRNA-378a-3p derived from extracellular vesicles secreted by blastocysts. Proc Natl Acad Sci USA 2022;119:e2122708119.
Alhattab D, Jamali F, Ali D, Hammad H, Adwan S, Rahmeh R, Samarah O, Salah B, Hamdan M, Awidi A. An insight into the whole transcriptome profile of four tissue-specific human mesenchymal stem cells. Regen Med 2019;14:841–865.
Heo JS, Choi Y, Kim H-S, Kim HO. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue. Int J Mol Med 2016;37:115–125.
Zhan X-S, El-Ashram S, Luo D-Z, Luo H-N, Wang B-Y, Chen S-F, Bai Y-S, Chen Z-S, Liu C-Y, Ji H-Q. A comparative study of biological characteristics and transcriptome profiles of mesenchymal stem cells from different canine tissues. Int J Mol Sci 2019;20:1485.
Monaco E, Sobreira de Lima A, Bionaz M, Maki A, Wilson SM, Hurley WL, Wheeler MB. Morphological and transcriptomic comparison of adipose and bone marrow derived porcine stem cells. Open Tissue Eng Regen Med J 2009;2:20–33.
Yamamoto Y, Banas A, Murata S, Ishikawa M, Lim CR, Teratani T, Hatada I, Matsubara K, Kato T, Ochiya T. A comparative analysis of the transcriptome and signal pathways in hepatic differentiation of human adipose mesenchymal stem cells. FEBS J 2008;275:1260–1273.
Yang Y, Wang H, Chang KH, Qu H, Zhang Z, Xiong Q, Qi H, Cui P, Lin Q, Ruan X. Transcriptome dynamics during human erythroid differentiation and development. Genomics 2013;102:431–441.
Muhl L, Genové G, Leptidis S, Liu J, He L, Mocci G, Sun Y, Gustafsson S, Buyandelger B, Chivukula IV. Single-cell analysis uncovers fibroblast heterogeneity and criteria for fibroblast and mural cell identification and discrimination. Nat Commun 2020;11:3953.
Sawicki S, Gurgul A, Gabryś J, Kij-Mitka B, Bochenek M, Karnas E, Podstawski Z, Długosz B, Bugno-Poniewierska M. Extracellular vesicles obtained from equine mesenchymal stem cells isolated from adipose tissue improve selected parameters of stallion semen after cryopreservation. Ann Anim Sci 2023;25:189–200.
Kroll KW, Mokaram NE, Pelletier AR, Frankhouser DE, Westphal MS, Stump PA, Stump CL, Bundschuh R, Blachly JS, Yan P. Quality control for RNA-Seq (QuaCRS): An integrated quality control pipeline.. Cancer Inform 2014;13:7–14.
Ge SX, Son EW, Yao R. iDEP: An integrated web application for differential expression and pathway analysis of RNA-Seq data.. BMC Bioinform 2018;19:534.
Kwong KS, Holland B, Cheung SH. A modified benjamini-hochberg multiple comparisons procedure for controlling the false discovery rate.. J Stat Plan Infer 2002;104:351–362.
Aparicio-Puerta E, Lebrón R, Rueda A, Gómez-Martín C, Giannoukakos S, Jaspez D, Medina JM, Zubkovic A, Jurak I, Fromm B. sRNAbench and sRNAtoolbox 2019: Intuitive fast small RNA profiling and differential expression.. Nucleic Acids Res 2019;47:W530–W535.
Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, Redl H, Rubin JP, Yoshimura K, Gimble JM. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy 2013;15:641–648.
Lara E, Rivera N, Cabezas J, Navarrete F, Saravia F, Rodriguez-Alvarez L, Castro F. Endometrial stem cells in farm animals: Potential role in uterine physi-ology and pathology.. Bioengineering 2018;5:75.
Marolt Presen D, Traweger A, Gimona M, Redl H. Mesenchymal Stromal Cell-Based Bone Regeneration Therapies: From Cell Transplantation and Tissue Engineering to Therapeutic Secretomes and Extracellular Vesicles.. Front Bioeng Biotechnol 2019;7:352.
Scotti C, Piccinini E, Takizawa H, Todorov A, Bourgine P, Papadimitropoulos A, Barbero A, Manz MG, Martin I. Engineering of a functional bone organ through endochondral ossification.. Proc Natl Acad Sci USA 2013;110:3997–4002.
Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, Tagliafico E, Ferrari S, Robey PG, Riminucci M. Self- renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment.. Cell 2007;131:324–336.
Brocher J, Janicki P, Voltz P, Seebach E, Neumann E, Mueller-Ladner U, Richter W. Inferior ectopic bone formation of mesenchymal stromal cells from adipose tissue compared to bone marrow: Rescue by chondrogenic pre-induction.. Stem Cell Res 2013;11:1393–1406.
Wei X, Liu Q, Guo S, Wu Y. Role of WNT5A in periodontal tissue development, maintance, and periodontitis: Implications for periodontal regeneration (Review). Mol Med Rep 2020;23:167.
Regard JB, Zhong Z, Williams BO, Yang Y. Wnt signaling in bone development and disease: Making stronger bone with Wnts.. Cold Spring Harb Perspect Biol 2012;4:a007997.
Nakanishi R, Akiyama H, Kimura H, Otsuki B, Shimizu M, Tsuboyama T, Nakamura T. Osteoblast-targeted expression of Sfrp4 in mice results in low bone mass.. J Bone Miner Res 2008;23:271–277.
Haraguchi R, Kitazawa R, Mori K, Tachibana R, Kiyonari H, Imai Y, Abe T, Kitazawa S. sFRP4-dependent Wnt signal modulation is critical for bone remodeling during postnatal development and age-related bone loss.. Sci Rep 2016;6:25198.
Robledo RF, Rajan L, Li X, Lufkin T. The Dlx5 and Dlx6 homeobox genes are essential for craniofacial, axial, and appendicular skeletal development.. Genes Dev 2002;16:1089–1101.
Kang S, Oh SC, Min BW, Lee DH. Transglutaminase 2 regulates self-renewal and stem cell marker of human colorectal cancer stem cells.. Anticancer Res 2018;38:787–794.
Laurentino TDS, Soares RDS, Marie SKN, Oba-Shinjo SM. LOXL3 Function Beyond Amino Oxidase and Role in Pathologies, Including Cancer.. Int J Mol Sci 2019;20:3587.
Zhang J, Yang R, Liu Z, Hou C, Zong W, Zhang A, Sun X, Gao J. Loss of lysyl oxidase-like 3 causes cleft palate and spinal deformity in mice.. Hum Mol Genet 2015;24:6174–6185.
Laverriere AC, MacNeill C, Mueller C, Poelmann RE, Burch JB, Evans T. GATA-4/5/6, a subfamily of three transcription factors transcribed in developing heart and gut.. J Biol Chem 1994;269:23177–23184.
Fujikura J, Yamato E, Yonemura S, Hosoda K, Masui S, Nakao K, Miyazaki J, Niwa H. Differentiation of embryonic stem cells is induced by GATA factors.. Genes Dev 2002;16:784–789.
Hasegawa S, Fujiwara T, Okitsu Y, Kato H, Sato Y, Fukuhara N, Onishi Y, Shimizu R, Yamamoto M, Harigae H. Effects of in vivo deletion of GATA2 in bone marrow stromal cells.. Exp Hematol 2017;56:31–45.
Kamata M, Okitsu Y, Fujiwara T, Kanehira M, Nakajima S, Takahashi T, Inoue A, Fukuhara N, Onishi Y, Ishizawa K. GATA2 regulates differentiation of bone marrow-derived mesenchymal stem cells.. Haematol 2014;99:1686–1696.
Bae S, Park CW, Son HK, Ju HK, Paik D, Koh GY, Kim J, Kim H, Jeon CJ. Fibroblast activation protein alpha identifies mesenchymal stromal cells from human bone marrow.. Br J Haematol 2008;142:827–830.
Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL, Franklin RA, McCubrey JA. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: A target for cancer chemotherapy.. Leukemia 2003;17:590–603.
Zhang WB, Zhong WJ, Wang L. A signal-amplification circuit between miR-218 and Wnt/beta-catenin signal promotes human adipose tissue-derived stem cells osteogenic differentiation.. Bone 2014;58:59–66.
Baboolal TG, Boxall SA, Churchman SM, Buckley CT, Jones E, McGonagle D. Intrinsic multipotential mesenchymal stromal cell activity in gelatinous Heberden’s nodes in osteoarthritis at clinical presentation.. Arthritis Res Ther 2014;16:R119.
Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, Blake J, Schwager C, Eckstein V, Ansorge W. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood.. Exp Hematol 2005;33:1402–1416.
Sottile M, Hocking C. Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions.. Mol Biol Cell 2002;13:3546–3559.
Ren Z, Hou Y, Ma S, Tao Y, Li J, Cao H, Ji L. Effects of CCN3 on fibroblast proliferation, apoptosis and extracellular matrix production.. Int J Mol Med 2014;33:1607–1612.
Jahan S, Mukherjee S, Ali S, Bhardwaj U, Choudhary R.K, Balakrishnan S, Naseem A, Mir S.A, Banawas S, Alaidarous M. Pioneer Role of Extracellular Vesicles as Modulators of Cancer Initiation in Progression, Drug Therapy, and Vaccine Prospects. Cells 2022;11:490.
Liu K, Cui Y, Han H, Guo E, Shi X, Xiong K, Zhang N, Zhai S, Sang S, Liu M. Fibroblast atlas: Shared and specific cell types across tissues. Sci. Adv. 2025;11:eado0173.
Quiros R.M, Valianou M, Kwon Y, Brown K.M, Godwin A.K, Cukierman E. Ovarian normal and tumor-associated fibroblasts retain in vivo stromal characteristics in a 3-D matrix-dependent manner. Gynecol. Oncol. 2008;110:99–109.
Vlieghe H, Leonel E.C.R, Asiabi P, Amorim C.A. The characterization and therapeutic applications of ovarian theca cells: An update. Life Sci. 2023;317:121479.
Plikus M.V, Wang X, Sinha S, Forte E, Thompson S.M, Herzog E.L, Driskell R.R, Rosenthal N, Biernaskie J, Horsley V. Fibroblasts: Origins, definitions, and functions in health and disease. Cell 2021;184:3852–3872.
Masi I, Ottavi F, Caprara V, Rio D.D, Kunkl M, Spadaro F, Licursi V, Tuosto L, Bagnato A, Rosano’ L. The extracellular matrix protein type I collagen and fibronectin are regulated by β-arrestin-1/endothelin axis in human ovarian fibroblasts. J. Exp. Clin. Cancer Res. 2025;44:64.
Kinnear H.M, Tomaszewski C.E, Chang A.L, Moravek M.B, Xu M, Padmanabhan V, Shikanov A. The ovarian stroma as a new frontier. Reproduction 2020;160:R25–R39.
Yun Y.R, Won J.E, Jeon E, Lee S, Kang W, Jo H, Jang J.H, Shin U.S, Kim H.W. Fibroblast growth factors: Biology, function, and application for tissue regeneration. J. Tissue Eng. 2010;2010:218142.